CRESCENT BIOPHARMA
Live / Applied — Non-final action mailed (as of 06 Jan 2026)
What this means for you
Not registered yet, but its 02 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99116433
- Mark type
- Stylized text
- Filed
- 02 Apr 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; House mark for pharmaceutical products for the treatment of cancer; Biologics in the nature of pharmaceutical preparations for the treatment of cancer; Antibodies for medical purposes, namely, for the treatment of cancer; none of the foregoing being analgesics
Owner
- Crescent Biopharma, Inc., Waltham, MA, US
Prosecution history
- 27 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION WRITTEN
- 10 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 19 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Aug 2025 — NON-FINAL ACTION E-MAILED